DOSSIER · 13F Holders · Q2 2026Healthcare · Pharmaceutical Preparations
ABCL
ABCELLERA BIOLOGICS INC
158 institutions still hold ABCELLERA BIOLOGICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 00288U106·Pharmaceutical Preparations·158 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
158 institutions reported ABCL in Q2 2026. Capital World Investors leads at 15.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 8
138 more holders available. Log in →